上海兆维 2026 年 7 月展会预告

展会信息

上海兆维科技发展有限公司（Hongene Biotech）将于 2026 年 7 月 10-11 号参加由佰傲谷 BioValley 主办，在北京悠唐皇冠假日酒店举行的 2026 第七届 QbD 生物药质量科学大会，届时会由蔡坤博士进行演讲展示。

第七届生物药质量科学大会以“筑牢质量基石，驱动产业未来”为宗旨，将在今年 7 月 10-11 日于北京启幕。历经六届深耕积淀与行业打磨，生物药质量科学大会（QbD）已成为国内生物药质量领域极具影响力、专业性与权威性的行业盛会，延续往届专业底蕴与行业使命，本届大会全面覆盖抗体、多肽、CGT 等成熟生物药领域，围绕关键质量属性分析、工艺表征、方法验证、监管合规等核心议题，助力行业深耕细作、提质增效。同时，大会紧跟生物药前沿发展趋势，精准捕捉行业创新热点，新增 in vivo CAR-T、小核酸等热门领域，将针对性覆盖这些前沿领域的质量管控难点与创新方向，构建“成熟领域深耕+热门领域拓展”的全方位、多层次会议体系。

本次大会将汇聚国内外生物药领域的权威专家、企业高管、科研学者、监管机构代表，围绕生物药全产业链质量管控核心痛点，开展专题分享、圆桌研讨、案例交流等多种形式的活动，助力中国生物药在创新与质量的双重引领下，提升全球竞争力，实现从“并跑”到“领跑”的跨越。

展会信息

上海兆维科技发展有限公司（Hongene Biotech）将于 2026 年 7 月 20-22 号参加由 Hanson Wade Group 主办，在美国·波士顿举行的 6th mRNA‑Based Therapeutics Summit，展位号 #26。

With science innovation at the core of the momentum, the 6th mRNA‑Based Therapeutics Summit returns to Boston this summer as the world's flagship meeting for the mRNA community. Bringing together 250+ global leaders – from pharma powerhouses to trailblazing biotech start‑ups including Moderna, Pfizer, AstraZeneca, Sanofi, ParcelBio, CaVos Therapeutics, Kernal Biologics to regulatory bodies including US FDA and EMA – the summit delivers exclusive breakthroughs, regulatory insights, and collaboration opportunities that are shaping the conversation and future of mRNA technology.

With a revitalized three‑track agenda covering Discovery, Pre‑Clinical & Clinical Development, and Manufacturing & CMC, plus two brand‑new focus days on AI‑Driven mRNA Design and Next‑Gen Delivery Technologies, this forum reaffirms its position as the go‑to hub for uniting top decision makers, showcasing scientific excellence, partnership building, and pipeline acceleration.

展会信息

上海兆维科技发展有限公司（Hongene Biotech）将于 2026 年 7 月 22-23 号参加由 IQ International 主办，在德国·法兰克福举行的 3rd Annual mRNA CONFERENCE EUROPE 2026，展位号 #4。

Welcome to the European mRNA Conference 2026, where global pharmaceutical and biotechnology leaders meet industry experts to explore innovations in mRNA therapeutics for vaccines, personalised medicine, and beyond.

This event explores the role of mRNA technology in developing novel treatments, covering research and development, clinical trials, large-scale manufacturing, and commercialisation. It highlights advances in RNA modification, therapeutic delivery systems, and vaccine development, showcasing the latest progress in mRNA medicine and oligonucleotide therapeutics.

Join us to explore next-generation mRNA therapeutics, gain valuable insights, and work together to shape the future of medicine.